Provided by Tiger Trade Technology Pte. Ltd.

Temasek Holdings

1,588.57
+4.830.30%
Number of Gainers:51
Number of Losers:28
Number of Flat:4
PE:- -
High:1,599.33
Open:1,583.69
Low:1,571.11
Close:1,583.74
Volume:628.40M
Turnover:81.25B
Market Cap:11.42T
Float Cap:10.62T

Loading ...

AI Boom Bypasses Legacy Industries, Highlighting Taiwan's 'Twin-Pace' Economic Divide

Deep News
·
Sep 08

Intellia Therapeutics Shares up 4.9% Premarket After FDA Accepts to Fast-Track Co's Treatment for a Rare Swelling Disorder

THOMSON REUTERS
·
Sep 08

August Jobs Report Surges Past Forecasts, Gold Faces Short-Term Pullback; Huafu Fund Sees Room for Rate-Hike Expectations to Retreat, Long-Term Investment Thesis Remains Solid

Deep News
·
Sep 08

Visa brings onchain lending into everyday payments

TIPRANKS
·
Sep 08

IFA Insights: China's Cross-Border E-Commerce Leaders Diverge as AliExpress Positions Itself as a Brand-Building Partner

Deep News
·
Sep 08

Airbnb is Maintained at Outperform by Baird

Dow Jones
·
Sep 08

Intellia Therapeutics announces FDA acceptance of lonvo-z BLA

TIPRANKS
·
Sep 08

Airbnb, Inc. : Raymond James Raises to Outperform from Market Perform

THOMSON REUTERS
·
Sep 08

Intel Stock Tops $100 Pre-Market as High-NA EUV Enters Mass Production, Trump Posts INTC Stock Chart Again

TradingKey
·
Sep 08

LG U+ launches Homecam Lite subscription with camera and insurance in South Korea

Deep News
·
Sep 08

Intellia Says FDA Accepts Lonvo-Z BLA for Hereditary Angioedema, Grants Priority Review

Reuters
·
Sep 08

Intellia Therapeutics, - FDA Accepts Bla for Lonvo-Z and Grants Priority Review with Pdufa Date March 10, 2027

THOMSON REUTERS
·
Sep 08

Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-Z) for Hereditary Angioedema (Hae)

THOMSON REUTERS
·
Sep 08

Intellia Therapeutics, - FDA not Planning to Hold Advisory Committee for Lonvo-Z Application

THOMSON REUTERS
·
Sep 08

【US Pre-Market】Middle East Energy Risks Escalate, Brent Crude Nears $100, Oil and Gas Stocks Rise; Novartis Plunges 13%

TradingKey
·
Sep 08

Beyond Oil: Washington Now Sets Its Sights on Venezuela's Gold and Critical Minerals

Deep News
·
Sep 08

Alibaba Reportedly Merges B2B Units Under New Leadership, No Official Comment Yet

Deep News
·
Sep 08

Arete Upgrades Sea to Buy From Neutral, Adjusts Price Target to $152 From $101

MT Newswires Live
·
Sep 08

Northland Securities Upgrades Intel to Outperform From Market Perform, $120 Price Target

MT Newswires Live
·
Sep 08

Huang Lichen: Bullion Rangebound as Investors Await Inflation Gauges

Deep News
·
Sep 08